Nestle gets peanut allergy treatment with $2 billion Aimmune buyout (Reuters) – Nestle (NESN.S) will pay $2 billion to buy the remaining stake in Aimmune Therapeutics Inc (AIMT.O), gaining full ownership of the [...]